Noxiptiline
Clinical data | |
---|---|
Trade names | Agedal, Elronon, Nogedal |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Noxiptiline (brand names Agedal, Elronon, Nogedal), also known as noxiptyline and dibenzoxine, is a tricyclic antidepressant (TCA) that was introduced in Europe in the 1970s for the treatment of depression.[2][3][4] It has imipramine-like effects,[5] acting as a serotonin and norepinephrine reuptake inhibitor, among other properties.[6][7] Of the TCAs, noxiptiline has been described as one of the most effective, rivaling amitriptyline in clinical efficacy.[8][9]
Synthesis
Ths synthesis is similar to that for Demexiptiline.
The condensation of dibenzosuberone (1) with hydroxylamine (2) gives the corresponding oxime [1785-74-6] (3). This is then reacted with 2-(dimethylamine)ethyl chloride [4584-46-7] (4).
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
- ISBN 3-88763-075-0.
- ISBN 978-0-444-53266-4.
- ISBN 0-412-54090-8.
- ISBN 0-8493-7774-9. Retrieved January 30, 2013.
- )
- S2CID 11641400.
- PMID 1687987.
- S2CID 44886111.
- PMID 5819763.
- PMID 5881239.
- ^ DE 1198353, Engelhard H, Engelhard N, Werth B, issued 1965, assigned to HERMANN ENGELHARD DR ING